**Core Concept:** Myoclonic epilepsy is a type of epilepsy characterized by brief, involuntary muscle jerks. In pregnancy, the aim of treatment is to control seizures without causing significant harm to the fetus. Drugs used in epilepsy treatment can be categorized into AEDs (antiepileptic drugs) that are safe for pregnancy and AEDs that are contraindicated due to potential harmful effects on the fetus.

**Why the Correct Answer is Right:**
During pregnancy, the preferred treatment for myoclonic epilepsy is **D**oxcarbazepine. Doxepin is a tricyclic antidepressant and is contraindicated in pregnancy due to its potential teratogenic effects. **Option A** (Doxepin) is incorrect because it can cause developmental abnormalities and miscarriages.

**Why Each Wrong Option is Incorrect:**
**Option B** (Carbamazepine) is not the correct choice because it has been associated with an increased risk of birth defects, particularly cardiovascular defects. **Option C** (Lamotrigine) is also incorrect due to potential risks for the fetus, including birth defects and increased risk of spontaneous abortion.

**Clinical Pearl:**
In pregnant patients with myoclonic epilepsy, choosing an AED with minimal risk to the fetus is crucial. Doxepin should be avoided due to its teratogenic effects. By using doxepin, healthcare professionals can effectively manage myoclonic seizures without compromising fetal wellbeing.

**Why Doxepin is not safe in pregnancy:**
Doxepin, a tricyclic antidepressant, has been linked to a higher risk of congenital anomalies, particularly cardiovascular defects, when used in pregnant women. This highlights the importance of selecting AEDs that pose minimal risk to the fetus, ensuring the best outcomes for both the mother and child.